Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Theseus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 12:36 pm Sale | 2023-12-31 | 13G | Theseus Pharmaceuticals, Inc. THRX | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -2,248,194 (Position Closed) | Filing |
| 2023-01-23 12:17 pm Purchase | 2023-01-13 | 13G | Theseus Pharmaceuticals, Inc. THRX | Frazier Life Sciences Public Fund, L.P. | 2,248,194 5.800% | 2,248,194 (New Position) | Filing |